RecruitingNot ApplicableNCT05733676

Comparison of MI Paste Plus and Resin Infiltration in White Spot Lesions Following Orthodontic Treatment

Comparison of MI Paste Plus and Resin Infiltration in Improvement of White Spot Lesions Following Fixed Orthodontic Treatment: A Randomized Controlled Trial


Sponsor

University of Alberta

Enrollment

62 participants

Start Date

May 30, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Dental cavities are among the most frequent diseases that affect teeth, particularly in patients who are treated with braces due to the difficulty in maintaining good oral hygiene in the presence of the mouth appliances. The white spot lesion (WSL) is the first clinical sign of cavities that presents itself as a milky-white opacity when located on the front face of the tooth. The aim to manage these early lesions focuses on promoting natural remineralization and preventing further demineralization. Various materials have been introduced for management of WSLs including MI paste and MI paste combined with fluoride (MI paste plus). Recently, a new material called resin infiltration has been found to treat these lesions with high esthetic results and great performance. According to the few numbers of in-vivo studies investigating the effectiveness of remineralization products, the aim of the current study is to clinically compare the outcome of the resin-infiltration and etching + MI paste plus to stop and improve the appearance of the WSL on front teeth in patients after treatment with braces.


Eligibility

Min Age: 12 YearsMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride and a medical device called Resin infiltration for people with caries arrested, orthodontic appliance complication, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 21 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEResin infiltration

Base line treatment of white spot lesions in smooth surface with Resin infiltration -Icon + etch, DMG, Germany.

DEVICECasein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride

Base line treatment of white spot lesions in smooth surface with MI paste plus + etch , GC corporation, Germany, Europe


Locations(1)

KAYE Edmonton Clinic

Edmonton, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05733676


Related Trials